Form 8-K - Current report:
SEC Accession No. 0001193125-24-205405
Filing Date
2024-08-22
Accepted
2024-08-22 17:00:30
Documents
13
Period of Report
2024-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d880241d8k.htm   iXBRL 8-K 22186
  Complete submission text file 0001193125-24-205405.txt   139714

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20240816.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20240816_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20240816_pre.xml EX-101.PRE 10807
16 EXTRACTED XBRL INSTANCE DOCUMENT d880241d8k_htm.xml XML 3576
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 241232678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)